Blog Posts by Date: Mar 2019

How Will Reimbursement be Managed in the Era of Precision Medicine and Value-Based Care?

If one were to ask the question: How will reimbursement be managed in the era of precision medicine and value-based care? The answer would require careful consideration. The precision medicine (PM) landscape continues to evolve due to the exponential growth, complexity and use of data in clinical decision making. With thousands of new diagnostic...


When It Comes to Billing and Cash Collection, Remote Patient Monitoring and Medical Device Companies Can Learn from Clinical Laboratories

As consumers, we often take for granted the experiences we have in pharmacies, physician offices, and sometimes even hospitals. In these situations, we have direct interactions with the service provider, and usually know ahead of time what we can expect in terms of cost. Sure, there are exceptions, but as a general rule, we have a better...


Key RCM Metrics Your Organization Should Monitor (and Why)

  • March 22, 2019

Developing highly efficient and effective revenue cycle management (RCM) processes is one of the fastest routes to financial improvement for laboratories. But, how do you know if your processes are effective for capturing the revenue you have earned? While there are several benchmarks that can provide value to your ongoing monitoring program,...


What are the Future Winning Strategies and Growth Opportunities for Clinical Laboratories?

  • March 14, 2019

Dissatisfaction for overall healthcare costs and the efficiency of care delivery in transitional settings like hospitals is opening the door for larger consumer companies to enter the healthcare market. Consumers are increasingly interested in gaining more control over their healthcare and information, and companies like Amazon and CVS can offer...


Simplifying Prior Authorizations

“That’s going to need a prior authorization” are words no healthcare provider, diagnostic provider, or patient wants to hear. Today, the process of obtaining prior authorizations is complex, disorganized, and highly manual. Patients often have no visibility into the process which leaves them frustrated, and in certain instances, they abandon...


Improve Reimbursement for Genomic Tests by Leveraging Real World Data

Since the sequencing of the human genome in 2003, genomic testing has become the fastest growing category of biomarker testing within the diagnostic laboratory industry. Many laboratory developed genomic tests use next-generation sequencing (NGS) as an approach to target numerous genomic variants with both proven and emerging evidence of clinical...